Enoxaparin Sodium Prices

Enoxaparin Sodium Price Trend, Index and Forecast

Track the latest insights on enoxaparin sodium price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.

Enoxaparin Sodium Prices Outlook Q2 2025

• United States: US$ 154000/Kg
• Germany: US$ 106000/Kg
• China: US$ 11000/Kg
• Brazil: US$ 141000/Kg
• India: US$ 26050/Kg

Enoxaparin Sodium Price Chart

Get real-time access to monthly/quaterly/yearly prices, Request Sample

During the second quarter of 2025, the enoxaparin sodium prices in the USA reached 154000 USD/Kg in June. In the USA, enoxaparin sodium prices were shaped by demand from the pharmaceutical and healthcare sectors, particularly hospitals and clinics. Supply was influenced by imports of raw materials and active pharmaceutical ingredients, with shipping rates and customs procedures affecting landed costs. Domestic manufacturing faced high energy and labor expenses, while compliance with strict Food and Drug Administration regulations added quality assurance costs. Distribution through extensive healthcare networks also contributed to overall procurement expenses.

During the second quarter of 2025, enoxaparin sodium prices in Germany reached 106000 USD/Kg in June. In Germany, enoxaparin sodium prices were influenced by consistent demand from the healthcare and pharmaceutical sectors. Production economics were impacted by raw material availability and energy tariffs in chemical manufacturing. Imports from other European Union countries and Asia supplemented supply, with freight charges and customs documentation shaping landed costs. Compliance with European Medicines Agency regulations increased testing and certification expenses, while labor and domestic logistics costs further added to distribution pressures across the healthcare system.

During the second quarter of 2025, the enoxaparin sodium prices in China reached 11000 USD/Kg in June. In China, enoxaparin sodium prices were driven by demand from hospitals, pharmaceutical manufacturers, and research institutions. Domestic production was shaped by access to heparin raw materials, feedstock availability, and energy tariffs. Regulatory compliance and stricter environmental controls on chemical and pharmaceutical production increased operational costs. Export demand to North America and Europe affected domestic allocation, while port logistics, inland transport, and currency fluctuations against the US dollar contributed to supply chain expenses.

During the second quarter of 2025, the enoxaparin sodium prices in Brazil reached 141000 USD/Kg in June. In Brazil, enoxaparin sodium prices were shaped by demand from public and private healthcare providers. The market relied significantly on imports of finished formulations and raw materials, making costs sensitive to global freight rates, port handling, and customs regulations. Currency volatility against the US dollar had a strong effect on procurement dynamics. Domestic logistics challenges, including long-haul trucking and infrastructure inefficiencies, added to distribution costs, while compliance with health regulatory standards increased certification expenses for suppliers.

During the second quarter of 2025, the enoxaparin sodium prices in India reached 26050 USD/Kg in June. In India, enoxaparin sodium prices were influenced by demand from hospitals, pharmaceutical companies, and export markets. Production economics were shaped by access to raw materials, energy tariffs, and local labor costs. Exports to Europe and North America influenced domestic supply balances, with shipping costs and customs documentation adding to overall expenses. Compliance with regulatory frameworks, including Good Manufacturing Practices and international quality certifications, increased operational costs, while domestic logistics inefficiencies further added to supply chain expenses.

Enoxaparin Sodium Prices Outlook Q2 2023

• China: US$ 24,000/Kg

The price of enoxaparin sodium in China for Q2 2023 reached 24,000 USD/Kg in June.

Regional Coverage

The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing the enoxaparin sodium prices.

Global Enoxaparin Sodium Price Trend

The report offers a holistic view of the global enoxaparin sodium pricing trends in the form of enoxaparin sodium price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price levels but also provides insights into historical price of enoxaparin sodium, enabling stakeholders to understand past fluctuations and their underlying causes. The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed enoxaparin sodium demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Enoxaparin Sodium Price Trend

Q2 2025:

As per the enoxaparin sodium price index, European enoxaparin sodium prices were shaped by steady demand from hospitals, clinics, and pharmaceutical distributors. Supply relied on both domestic manufacturers and imports, with freight charges, customs compliance, and port handling shaping landed costs. Feedstock availability for heparin production influenced raw material expenses, while high energy tariffs and labor costs in pharmaceutical manufacturing hubs increased operational pressures. European Medicines Agency regulations required extensive testing, certification, and traceability, adding compliance-related costs. Distribution logistics across multiple countries within the region further contributed to overall procurement dynamics.

Q2 2023:

European enoxaparin sodium prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed enoxaparin sodium price information for a comprehensive list of countries.

North America Enoxaparin Sodium Price Trend

Q2 2025:

As per the enoxaparin sodium price index, in North America, enoxaparin sodium prices were influenced by strong demand from the healthcare sector, particularly hospitals and large pharmacy networks. Supply was impacted by a mix of domestic production and imports, with shipping costs, port congestion, and customs clearance affecting landed expenses. Feedstock sourcing for heparin derivatives played a crucial role in production economics. Compliance with strict Food and Drug Administration regulations added quality assurance and certification costs. Additionally, inland transportation, warehousing, and labor availability shaped distribution and final procurement costs across healthcare providers.

Q2 2023:

The analysis of enoxaparin sodium prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific enoxaparin sodium historical data within the United States and Canada can also be provided.

Middle East and Africa Enoxaparin Sodium Price Trend

Q2 2025:

As per the enoxaparin sodium price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences. A tight supply from refineries, exacerbated by maintenance rounds and unplanned outages, put pressure on prices. Simultaneously, demand from the agrochemical sector during the planting season contributed to price changes.

Q2 2023:

The report explores the enoxaparin sodium pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on enoxaparin sodium prices for countries can also be provided.

Asia Pacific Enoxaparin Sodium Price Trend

Q2 2025:

In Asia Pacific, enoxaparin sodium prices were driven by demand from healthcare systems, pharmaceutical manufacturers, and export markets. China and India played leading roles in production, with costs influenced by access to raw materials, energy tariffs, and local labor availability. Export commitments to Europe and North America influenced domestic allocation, while logistics, including inland transport and port operations, shaped supply chain expenses. Regulatory compliance with international standards, including Good Manufacturing Practices and export certifications, further increased operational costs across regional producers.

Q2 2023:

The enoxaparin sodium pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This enoxaparin sodium price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Enoxaparin Sodium Price Trend

Q2 2025:

In Latin America, and particularly Brazil, enoxaparin sodium prices were influenced by demand from both public and private healthcare providers. Heavy reliance on imports made costs sensitive to international freight charges, customs requirements, and port handling. Currency volatility of the Brazilian real against the US dollar significantly impacted procurement expenses. Domestic logistics, including long-haul trucking and infrastructure inefficiencies, further increased distribution costs. Compliance with health regulatory standards for pharmaceutical imports added additional certification and testing expenses, shaping overall supply chain economics in the region.

Q2 2023:

The analysis of enoxaparin sodium prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Enoxaparin Sodium Price Trend, Market Analysis, and News

IMARC's latest publication, “Enoxaparin Sodium Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents a detailed examination of the enoxaparin sodium market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of enoxaparin sodium at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed enoxaparin sodium prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting enoxaparin sodium pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.

Enoxaparin Sodium Market Analysis

The global enoxaparin sodium market size reached USD 4.19 Billion in 2024. By 2033, IMARC Group expects the market to reach USD 10.13 Billion, at a projected CAGR of 9.79% during 2025-2033.

• In surgical settings, enoxaparin sodium is extensively used as a prophylactic agent to prevent postoperative thromboembolic complications. The chances of venous thromboembolism (VTE) occurring in major orthopedic surgeries, such as hip or knee replacement, are very high. Enoxaparin sodium massively decreases this occurrence. It is also used for abdominal surgery among patients who are suffering from malignancies and those undergoing general surgeries who are at risk of thromboembolism. By preventing the blood from forming clots, it minimizes the risk of any complications that may be life-threatening after surgery. Further, the increased geriatric populations worldwide are increasing the scope for successful orthopedic surgery. As per the India Ageing Report 2023 by the United Nations Population Fund, by 2046, the old population of India will outnumber the population of children between the ages of 0 and 15 years.
• Moreover, enoxaparin sodium plays a significant role in the management of acute coronary syndromes (ACS), including unstable angina and non-ST-segment elevation myocardial infarction (NSTEMI). It helps stabilize the patient by reducing the risk of further thrombus formation and subsequent cardiac events. In conjunction with other therapies, such as antiplatelet agents, enoxaparin sodium is part of the standard treatment protocol to improve patient outcomes in these critical conditions.
• Enoxaparin sodium is very useful in cases of VTE in pregnancy. Physiological changes during pregnancy make the chances of a thromboembolic event higher for a pregnant woman. Enoxaparin sodium is usually preferred because it does not cross over the placenta, hence safer for the fetus compared to other anticoagulants, such as warfarin. It is used both for the prophylaxis and treatment of VTE in pregnant women, ensuring that the mother is healthy without risking the safety of the fetus. Pregnant women who face complications are more likely to have complications in subsequent pregnancies, as stated in Pregnancy Statistics (2024) from Forbes Health. This is raising awareness and promoting the use of effective medications such as enoxaparin sodium by healthcare providers.
• Cancer patients are at an increased risk of VTE because of a hypercoagulable state related to malignancy itself and its therapy. Enoxaparin sodium is counted in the list of most frequently used agents for primary and secondary thromboprophylaxis of VTE in the population.

Enoxaparin Sodium News

The report covers the latest developments, updates, and trends impacting the global enoxaparin sodium market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in enoxaparin sodium production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the enoxaparin sodium price trend.

Latest developments in the enoxaparin sodium industry:

• In 2023: Techdow USA announced the launch of its 30mg, 40mg, 60mg, 80mg, 100mg, 120mg, and 150mg strengths of generic Lovenox (Enoxaparin Sodium- preservative free).
• In 2023: Meitheal Pharmaceuticals, Inc. declared that it will start distributing the enoxaparin sodium injection, USP pre-filled syringes with certain changes.

Product Description

Enoxaparin Sodium is a low molecular weight heparin (LMWH) derived from unfractionated heparin. It functions primarily as an anticoagulant, preventing the formation of blood clots. It has a higher bioavailability and a longer half-life, permitting once or twice-daily dosing. It is essential in the prevention and management of thromboembolic disorders, which are associated with significant morbidity and mortality. It significantly reduces the incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE) in postoperative patients, thus improving surgical outcomes. It enhances patient adherence and convenience, especially in outpatient settings where prolonged anticoagulation therapy might be required. It is used to prevent clotting in the dialysis circuit. It ensures the smooth operation of dialysis sessions and reduces the risk of clot-related complications. In pregnancy, Enoxaparin offers a safe and effective option for preventing and treating VTE. Its ability to prevent clot formation without crossing the placenta ensures that both maternal and fetal health are safeguarded.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of enoxaparin sodium pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting enoxaparin sodium price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The enoxaparin sodium price charts ensure our clients remain at the forefront of the industry.